PHR
$11.19
Phreesia, Inc.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers an appointment scheduling system for online appointments, reminders, and referral tracking ...
Recent News
How The Phreesia (PHR) Story Is Shifting As Price Targets Fall And AI Tools Grow
Phreesia is back in focus as analysts trim price targets into the US$24 to US$26 range, while the modelled fair value in this update holds steady at US$28.05 per share. That gap reflects the current debate you are seeing in recent research, where firms are weighing execution on the path to profitability against questions about how much investors are willing to pay for growth in health tech. Read on to see what is driving this evolving narrative and how you can track it from here. Stay updated...
CareCloud, Inc. (CCLD) Q4 Earnings Match Estimates
CareCloud (CCLD) delivered earnings and revenue surprises of 0.00% and +5.30%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Conestoga Capital Advisors Remains Confident in Phreesia (PHR) Amid Challenges
Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2025 investor letter. US equities experienced solid returns in 2025, with double-digit gains across all major indices. A copy of the letter can be downloaded here. In 2025, the Conestoga Micro Cap Composite met its purpose of preserving capital during negative market returns and capturing upside […]
What Catalysts Are Rewriting The Phreesia (PHR) Narrative After Recent Analyst Resets
Phreesia's latest valuation update reflects a small reset in expectations, with the fair value estimate adjusted slightly lower from US$28.63 to US$28.32 per share as analysts fine tune their models. Behind that, the discount rate edges down from 8.25% to 8.21% and revenue growth assumptions stay broadly steady at about 11.71%, suggesting the real shift is more about risk appetite and confidence in the story than a wholesale rethink of the business. As this narrative keeps evolving, it is...
How Phreesia’s Story Is Shifting As Analyst Price Targets Are Reassessed
Why Phreesia’s Price Target Just Changed Phreesia’s latest price target update marks a fresh chapter in how analysts are framing the stock, even though the specific prior and new targets were not disclosed. With no detailed commentary provided, the change itself indicates that expectations around the company are being reassessed and monitored. Investors may want to follow future updates and research coverage to understand how these shifts fit into the broader Phreesia story. Analyst Price...